SAMN45062380
External Id
dbGaP
INSDC center name
2024-11-26T12:10:34.727Z
INSDC first public
2024-12-06T05:41:38.367Z
INSDC last update
SRS23424689
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS23424689
SRA accession
DNA
analyte type
NCI_AtezolizumabChemoradiotherapyCervicalCancer
biospecimen repository
GADKGW-0CLJKZ_TCRB
biospecimen repository sample id
BLOOD
body site
phs003833
gap_accession
7029077
gap_sample_id
5302199
gap_subject_id
No
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
sex
Clinical Trial
study design
Uterine Cervical Neoplasms
study disease
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
study name
Yes
subject is affected
GADKGW-0CLJKZ_TCRB
submitted sample id
GADKGW
submitted subject id
NCI_AtezolizumabChemoradiotherapyCervicalCancer
submitter handle
Non-tumor DNA sample from BLOOD of a human female participant in the dbGaP study "NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer"
title